Kidney International

Article	Citations
Subscription Information	1191
Back off to better blow up: acute GFR decrease at SGLT-2 inhibitor initiation	809
The authors reply	594
The latest model has just arrived! A new experimental mouse model of PLA2R1-associated membranous nephropathy	508
Table of Contents	286
An unusual case of ascites after kidney transplantation	273
In this issue	262
The authors reply:	248
The Case | Euglycemic ketoacidosis in a patient on continuous renal replacement therapy	196
Enough is enough: targeted eculizumab withdrawal in atypical hemolytic uremic syndrome	168
Journal Club	166
Sex differences in cardiovascular disease burden in children with chronic kidney disease	144
In This Issue	144
Subscription Information	142
In this issue	138
Editorial Board	135
Acute heart failure in a kidney transplant patient	134
James P. Knochel, MD, 1930–2022	130
Journal Club	124
Challenges in maturation and integration of kidney organoids for stem cell–based renal replacement therapy	120
Resazurin dye is an in vivo sensor of kidney tubular function	118
TRAIL induces podocyte PANoptosis via death receptor 5 in diabetic kidney disease	118
Caloric restriction reduces the pro-inflammatory eicosanoid 20-hydroxyeicosatetraenoic acid to protect from acute kidney injury	111
Epigenetic alterations and memory: key players in the development/progression of chronic kidney disease promoted by acute kidney injury and diabetes	108
Thirsty encounters of the third kind	107

Utility of new image-derived biomarkers for autosomal dominant polycystic kidney disease prognosis using automated instance cyst segmentation	106
Fluid volume management in hemodialysis: never give up!	102
Editorial Board	100
Subscription Information	98
Journal Club	97
The authors reply	97
Strawberry gingivitis	97
Acknowledgment of reviewers	94
The Case | Hematuria and hypercalcemia in a kidney transplant recipient	93
The authors reply	92
Table of Contents	90
Interference of urinary albumin-to-creatinine ratio measurement by glycosuria: clinical implications when using SGLT-2 inhibitors	84
In this issue	83
Going rogue: how autoantibodies become pathogenic	80
The authors reply	78
in this issue	75
Table of Contents	71
Insights from the BKEVER Trial comparing everolimus versus mycophenolate mofetil for BK Polyomavirus infection in kidney transplant recipients	70
Tubular handling of filtered albumin	70
Editorial Board	70
In this issue	70
The Case | A paraneoplastic kidney injury?	69
In memoriam: Donal O’Donoghue, 1956–2021	69
Editorial Board	69
Polyploid tubular cells and chronic kidney disease	68
A PHD inhibitor prevents changes in the phosphoproteome and capillary rarefaction by CsA: treatment option for CKD?	68
Dietary sodium restriction in heart failure and chronic kidney disease: more evidence emerges	68
The authors reply	67
Journal Club	67
The spectrum of glomerular and vascular kidney pathology associated with myeloproliferative neoplasms	66
The authors reply	66
Table of Contents	66
In This Issue	65
TAMEing ADPKD with metformin: safe and effective?	64
Subscription Information	64
Editorial Board	62
Table of Contents	62
Subscription Information	61
Acute kidney injury and “clogged chimneys”	61
Endogenous adenine as a key player in diabetic kidney disease progression: an integrated multiomics approach	61
Genetic insights into rapid kidney function decline	61
Maybe the various forms of kidney disease are not so mechanistically different?	61
Gene editing: a near future for the treatment of genetic kidney diseases	60
In remembrance of Eberhard Ritz, MD (1938–2023)	60
The Case | Hypereosinophilia in a hemodialysis patient	59
Subscription Information	58
Do the benefits of subcutaneous immunoglobulin therapy for secondary hypogammaglobulinemia in ANCA vasculitis extend beyond infection prevention?	58
Editorial Board	58
War in Ukraine	58
In memoriam: Shaul G. Massry	55

in this issue	55
Eculizumab impairs killing of Neisseria meningitidis serogroup B in atypical hemolytic uremic syndrome patients vaccinated with MenB-4C	55
Tolvaptan to prevent calcium oxalate crystal deposition in the kidney allograft after kidney transplantation for primary hyperoxaluria	54
Function follows form: the quest for the best prognostic imaging biomarker in ADPKD	54
Looking back and moving forward	53
Granuloma formation after peritoneal dialysis catheter–related infection by Mycobacterium chelonae	52
JournalClub	51
in this issue	51
Editorial Board	51
Endovascular treatment of nutcracker syndrome	51
Challenges in the development of novel methodologies for measuring glomerular filtration rate	51
Myeloid bodies in acute tubular injury	51
Anti-aging mechanism of calorie restriction in humans	50
micro-RNA-486-5p protects against kidney ischemic injury and modifies the apoptotic transcriptome in proximal tubules	50
Could Plasmodium falciparum–related kidney disease stand as another example of interferonopathy?	50
IgA nephropathy presenting as macroscopic hematuria in 2 pediatric patients after receiving the Pfizer COVID-19 vaccine	50
The spatially resolved transcriptional profile of acute T cell–mediated rejection in a kidney allograft	48
Plasma cadmium is associated with increased risk of long-term kidney graft failure	48
The ROMANOV study found impaired humoral and cellular immune responses to SARS-CoV-2 mRNA vaccine in virus-unexposed patients receiving maintenance hemodialysis	48
All the might of the osteocyte: emerging roles in chronic kidney disease	48
A machine learning–based radiomic model for predicting urinary infection stone	46
Subscription Information	46
Both hyperglycemia and hyperuricemia aggravate acute kidney injury during cholesterol embolism syndrome despite opposite effects on kidney infarct size	46
Title Page	45
Table of Contents	45
Prioritizing water stewardship in kidney replacement therapies	45
Should we consider calcimimetics as a therapeutic option for nephrotic syndrome?	44
APOL1 genotyping in kidney transplantation: to do or not to do, that is the question? (contra)	44
Shifting the focus from managing the failing kidney allograft to supporting the patient with a failing kidney allograft	44
A key gene in Drosophila eye development provides protection for tubules and glomeruli upon injury	43
Oncogenic osteomalacia related to an intramuscular mesenchymal tumor of the scalene muscles	43
Renovascular hypertension secondary to massive iliopsoas hematoma	43
Molecular programs associated with glomerular hyperfiltration in early diabetic kidney disease	42
journal club	42
Antibody and T-cell response to a third dose of SARS-CoV-2 mRNA BNT162b2 vaccine in kidney transplant recipients	42
Parathyroid hormone oxidation in chronic kidney disease: clinical relevance?	42
Editorial Board	42
A case of ANCA-associated vasculitis after AZD1222 (Oxford–AstraZeneca) SARS-CoV-2 vaccination: casualty or causality?	42
Unlocking the potential of extracellular vesicles in nephrology: what does MISEV2023 add?	41
Unpicking the multiomic response to endurance training: relevance for exercise benefits in chronic kidney disease	41
Journal Club	40
Table of Contents	40
A single approach to targeting transferrin receptor 2 corrects iron and erythropoietic defects in murine models of anemia of inflammation and chronic kidney disease	40
Long-term glomerular dysfunction after childhood cancer nephrectomy: what is the impact of nephrectomy and obesity?	40
A retrospective cohort study predicting and validating impact of the COVID-19 pandemic in individuals with chronic kidney disease	39
Immune checkpoint inhibitor–associated electrolyte disorders: query of the Food and Drug Administration Adverse Event Reporting System	39
Do we need to treat chronic active T cell–mediated rejection?	39
The urgent need to vaccinate dialysis patients against severe acute respiratory syndrome coronavirus 2: a call to action	39
Posaconazole-induced podocyte phospholipidosis	39
Antibody response to COVID-19 booster vaccine in rituximab-treated patients with anti–neutrophil cytoplasmic antibody–associated vasculitis	39
Effect of disease progression on the podocyte cell cycle in Alport Syndrome	39
Renin-angiotensin aldosterone inhibitor use at hospital discharge among patients with moderate to severe acute kidney injury and its association with recurrent acute kidney injury and mortality	39
Noninvasive screening of vancomycin-associated cast nephropathy	39
Perirenal IgG4-related disease	38
Tubular glycogen nuclei in a patient with glycogen storage disease type Ia	38
The Case | Late allograft dysfunction with unexpected biopsy findings	38
Editorial Board	38
Calculated versus measured albumin-creatinine ratio to predict kidney failure and death in people with chronic kidney disease	37
Misuse of the Cox proportional hazards model and alternative approaches in kidney outcome research	37
Diet–microbiota interaction and kidney disease progression	37
Measurement of urinary Dickkopf-3 uncovered silent progressive kidney injury in patients with chronic obstructive pulmonary disease	37
Seeing through the density of dense deposit disease	36
Bacillus Calmette-Guérin–induced kidney granulomas	36
Renin and renin blockade have no role in complement activity	35
Novel mechanisms of salt-sensitive hypertension	35
Any reduction in maternal kidney mass makes a difference during pregnancy in gestational and fetal outcome	35
Single-cell lineage tracing approaches to track kidney cell development and maintenance	35
The ASCEND-NHQ randomized trial found positive effects of daprodustat on hemoglobin and quality of life in patients with non-dialysis chronic kidney disease	35
Cardiac tamponade diagnosed on nephrologist-performed point-of-care ultrasonography	35
The authors reply	35
The authors reply	35
The state of the global nephrology workforce: a joint ASN–ERA-EDTA–ISN investigation	34
Modelling AKI in vitro: taking organoids to the next level	34
Hereditary hypophosphatemic rickets with hypercalciuria (HHRH), a complex disorder in need of precision medicine	34
Current kidney function parameters overestimate kidney tissue repair in reversible experimental kidney disease	34
Lipoic acid supplementation associated with neural epidermal growth factor-like 1 (NELL1)–associated membranous nephropathy	34
Bone histomorphometry for the diagnosis of renal osteodystrophy: a call for harmonization of reference ranges	34
Identification of the gut microbial enzyme turning the urine yellow	34
A randomized, open-label, clinical trial examined the effects of canagliflozin on albuminuria and eGFR decline using an individual pre-intervention eGFR slope	34
Dialysis modality and quality of life: more answers yet more questions	34

Targeting WIP1 phosphatase promotes partial remission in experimental collapsing glomerulopathy	34
The randomized controlled trial (NAVKIDS2) of a patient navigator program created for children with chronic kidney disease	33
Looking into the cholesterol crystal ball: is complement the answer?	33
SGLT-2 inhibition in IgA nephropathy: the new standard of care?	33
Deregulating iron-erythropoiesis regulation: transferrin receptor 2 as potential target for treating anemia in CKD	33
Including APOL1 alleles and ancestry adjustments improve a genome-wide polygenic CKD score	33
A novel nanoluciferase transgenic reporter measures proteinuria in zebrafish	33
The authors reply	33
A pig kidney supporting human physiology	33
Inadvertent stem cell transfer demonstrating a way for tolerance induction	33
Idiopathic collapsing glomerulopathy is associated with APOL1 high-risk genotypes or Mendelian variants in most affected individuals in a highly admixed population	33
Development of an adaptive clinical web-based prediction tool for kidney replacement therapy in children with chronic kidney disease	33
Age-related changes in nephrosclerosis in a multiethnic living kidney donor cohort	33
Complement in membranous nephropathy: what we thought we knew and what we really know	32
A fast and simple clearing and swelling protocol for 3D in-situ imaging of the kidney across scales	32
A novel claudin-10 mutation with a unique mechanism in two unrelated families with HELIX syndrome	32
Enhancing kidney organoid maturity with inducible vascularization: another step forward for in vitro modeling	32
Shared decision-making in hemodialysis vascular access practice	31
Dysfunction of the circadian clock in the kidney tubule leads to enhanced kidney gluconeogenesis and exacerbated hyperglycemia in diabetes	31
A comprehensive assessment of long-term SARS-CoV-2–specific adaptive immune memory in convalescent COVID-19 Solid Organ Transplant recipients	31
A team-based approach for testing biomarkers of kidney disease progression	31
Multidisciplinary approaches for elucidating genetics and molecular pathogenesis of urinary tract malformations	31
Machine learning: it takes more than select models to draw general conclusions	30
A stepped wedge cluster randomized trial of graphical surveillance of kidney function data to reduce late presentation for kidney replacement therapy	30
Anti–SARS-CoV-2 spike protein S1 receptor-binding domain antibody after vaccination with inactivated whole-virus SARS-CoV-2 in end-stage kidney disease patients: an initial report	30
Reconstructing the interface between the human intestine and immune system: potential to advance mechanistic studies in IgA nephropathy	30
Murine models of uremic cardiomyopathy as a necessary tool to unravel mechanisms involved in cardiorenal syndrome	29
A population-based cohort defined risk of hyperkalemia after initiating SGLT-2 inhibitors, GLP1 receptor agonists or DPP-4 inhibitors to patients with chronic kidney disease and type 2 diabetes	29
Antibody response to the BNT162b2 vaccine in maintenance hemodialysis patients	29
When the pooled CRISPR screen meets kidney organoids: toward the identification of new genes and pathways	29
PI3Kα in the pathogenesis and treatment of lupus nephritis	29
Urine trumps the protocol biopsy for subclinical rejection surveillance	28
Glomerular-tubular crosstalk via cold shock Y-box binding protein-1 in the kidney	28
Models of care to address disparities in kidney health outcomes for First Nations people	28
Taking the amphoterism out of amphotericin: a wonder drug in the making	28
SARS-CoV-2–reactive cellular and humoral immunity in hemodialysis population	28
Performance of the Cockcroft-Gault, Modification of Diet in Renal Disease, and new Chronic Kidney Disease Epidemiology Collaboration equations without race in older acute medical patients	28
The impact of genetic background on mouse models of kidney disease	28
An international cohort study spanning five decades assessed outcomes of nephropathic cystinosis	28
A mutation in the SAA1 promoter causes hereditary amyloid A amyloidosis	27
A case of membranous nephropathy following Pfizer–BioNTech mRNA vaccination against COVID-19	27
How the amyloid fibril has unraveled: lessons for nephrology	27
My, oh, MYO9A! Just how complex can regulation of the podocyte actin cytoskeleton get?	27
Editorial Board	27
Phosphate meeting cholesterol—consequences for cardiovascular disease in chronic kidney disease?	27
Development and testing of an artificial intelligence tool for predicting end-stage kidney disease in patients with immunoglobulin A nephropathy	26
Unfair enough: the cosmetic-TIM-kidney syndromes	26
Dietary potassium loads call on intercalated cell PIEZO1 to go with the flow	26
Deciphering the kidney hemodynamic effects of SGLT2 inhibition: translating insights from rats to humans in type 2 diabetes	26
The authors reply	26
Complement alternative pathway determines disease susceptibility and severity in antineutrophil cytoplasmic antibody (ANCA)–associated vasculitis	26
The Case | Obstructive acute renal failure due to acute uric acid nephrolithiasis	26
Tissue-resident macrophages mediate neutrophil recruitment and kidney injury in shiga toxin-induced hemolytic uremic syndrome	25
A small molecule chaperone rescues keratin-8 mediated trafficking of misfolded podocin to correct genetic Nephrotic Syndrome	25
Use of antibiotics as a therapeutic approach to prevent AKI-to-CKD progression	25
journal club	25
Unusual cause of retroperitoneal leak in a patient undergoing peritoneal dialysis	25
The authors reply	25
Improving and maintaining quality of hemodialysis in areas affected by war: a call to action!	25
A well-developed endolysosomal system reflects protein reabsorption in segment 1 and 2 of rat proximal tubules	25
Monoclonal immunoglobulin crystalline nephropathies	25
Editorial Board	25
Spatially resolved transcriptomics and the kidney: many opportunities	25
Soluble guanylate cyclase as a direct target for pharmacologic mitigation of chronic kidney disease	24
Corrigendum to Tokonami N, Olinger E, Debaix H, Houillier P, Devuyst O. The excretion of uromodulin is modulated by the calcium-sensing receptor. Kidney Int. 2018;94:882–886	24
Deletion of protein tyrosine phosphatase SHP-1 restores SUMOylation of podocin and reverses the progression of diabetic kidney disease	24
Age- and sex-dependent kidney failure risk in 25- to 95-year-old Germans	24
Corrigendum to “A novel nanoluciferase transgenic reporter measures proteinuria in zebrafish.” Kidney Int. 2022;102:815–827	24
Unexpected metabolic effects of sodium-glucose cotransporter 2 inhibitors	24
Subscription Information	24
Matrix metalloproteinase-9 regulates afferent arteriolar remodeling and function in hypertension-induced kidney disease	24
Corrigendum to “Acute kidney injury genetic risks: taking it 1 SNP at a time.” Kidney International 2024;106:188–190	24
Editorial Board	23
Ttc21b deficiency attenuates autosomal dominant polycystic kidney disease in a kidney tubular- and maturation-dependent manner	23
Endothelial but not systemic ferroptosis inhibition protects from antineutrophil cytoplasmic antibody-induced crescentic glomerulonephritis	23
Subscription Information	23
journal club	23
Post-hoc analysis of the CARES trial suggests delayed progression of chronic kidney disease in patients with gout during urate-lowering therapy	23
Somatic mutations acquired during life: state of the art and implications for the kidney	23
Taking the A(llorecognition) train: connecting passenger T cells to DSA	23
Choosing fluids to reduce the risks of acute electrolyte disturbances in children after a kidney transplant	23
Blood pressure adaptation in vertebrates: comparative biology	23
Tubular albumin uptake: is there evidence for a quantitatively important, receptor-independent mechanism?	22
Altered vitamin K biodistribution and metabolism in experimental and human chronic kidney disease	22
The mechanosensitive ion channel Piezo1 contributes to podocyte cytoskeleton remodeling and development of proteinuria in lupus nephritis	22
Treatment of patients with IgA nephropathy: a call for a new paradigm	22
On the relevance of thrombomodulin variants in atypical hemolytic uremic syndrome	22
Biallelic pathogenic variants in roundabout guidance receptor 1 associate with syndromic congenital anomalies of the kidney and urinary tract	22
The role of sex and gender in acute kidney injury—consensus statements from the 33rd Acute Disease Quality Initiative	22
Anti-Nephrin Antibodies in Adult Chinese Patients with Minimal Change Disease and Primary Focal Segmental Glomerulosclerosis	22
Rationale and design of the Nephrotic Syndrome Study Network (NEPTUNE) Match in glomerular diseases: designing the right trial for the right patient, today	22
Klotho-derived peptide 6 ameliorates diabetic kidney disease by targeting Wnt/β-catenin signaling	22
Dynamic single cell transcriptomics defines kidney FGF23/KL bioactivity and novel segment-specific inflammatory targets	22
Hydroxycobalamin-induced pigmented effluent during dialysis	22
Certain heterozygous variants in the kinase domain of the serine/threonine kinase NEK8 can cause an autosomal dominant form of polycystic kidney disease	21